Journal
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 11, Issue 6, Pages 604-611Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2012.12.039
Keywords
Hepatocellular Carcinoma; Chemoembolization; Radioembolization
Categories
Funding
- National Institutes of Health [CA126809]
Ask authors/readers for more resources
Hepatocellular carcinoma (HCC) continues to represent a major worldwide problem. Although treatments such as resection, transplantation, and ablation may provide a chance for a cure, these options are often precluded because of advanced disease presentation. Palliative treatments include transarterial embolization and systemic therapies. This review will summarize the state of the science for embolic therapies in HCC (conventional and drug-eluting chemoembolization, radioembolization) as well as discuss related topics including HCC staging, assessment of response, and ongoing clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available